Inferior Turbinate Surgery in Rhinoseptoplasty: a Randomized Clinical Trial With Quality of Life Outcomes

January 16, 2019 updated by: Hospital de Clinicas de Porto Alegre

Inferior Turbinate Surgery in Rhinoseptoplasty: a Randomized Clinical Trial With Quality of Life and Acoustic Rhinometry Outcomes

The purpose of this study is to determine whether inferior turbinate surgery during rhinoseptoplasty is effective in improving quality of life and acoustic rhinometry outcomes.

Study Overview

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Rio Grande Do Sul
      • Porto Alegre, Rio Grande Do Sul, Brazil
        • Hospital de Clínicas de Porto Alegre

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Older than 15 years old;
  • Nasal obstruction and nasal aesthetics complaints;

Exclusion Criteria:

  • Previous septoplasty, turbinates intervention and/or rhinoplasty;
  • Association of other surgical procedures in the same surgical time, as functional endoscopic sinus surgery, blepharoplasty, mentoplasty or otoplasty;
  • Inferior turbinate hypertrophy as the isolated cause of nasal obstruction (no septum deviation or internal valve collapse)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Sham Comparator: No inferior turbinate surgery
During rhinoseptoplasty there is no intervention on inferior turbinates
During rhinoseptoplasty no intervention is done in inferior turbinates
Experimental: Inferior Turbinate surgery
During rhinoseptoplasty, inferior turbinate submucosal cauterization is performed.
During rhinoseptoplasty inferior turbinate submucosal cauterization is performed.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Nasal Obstructive Symptoms Evaluation Scale
Time Frame: 3 months postop
Specif instrument for evaluation of quality of life related to nasal obstruction
3 months postop

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Acoustic Rhinometry
Time Frame: 3 months post-op
3 months post-op
World Health Organization Quality of Life (WHOQOL)
Time Frame: 3 months postop
quality of life instrument
3 months postop
Rhinoplasty Outcomes Evaluation
Time Frame: 3 months postop
quality of life for rhinoplasty patients
3 months postop
Allergic Conjunctivitis
Time Frame: 3 months postop
At 90 posoperative day patients were asked if they had allergic conjunctivitis for more than one hour a day on most days, or not.
3 months postop
Nasal Rhinorrea
Time Frame: 3 months postop
At 90 posoperative day patients were asked if they had nasal rhinorrea for more than one hour a day on most days, or not.
3 months postop
Nasal pruritis
Time Frame: 3 months posopt
At 90 posoperative day patients were asked if they had nasal pruritis for more than one hour a day on most days, or not.
3 months posopt
Nasal Sneeze
Time Frame: 3 months postop
At 90 posoperative day patients were asked if they had nasal sneeze for more than one hour a day on most days, or not.
3 months postop
Topic nasal corticosteroid
Time Frame: 3 months
At 90 posoperative day patients were asked if they were using topic nasal corticosteroid or not.
3 months
Oral antihistamine
Time Frame: 3 months
At 90 posoperative day patients were asked if they had used oral antihistamine in the past 30 days or not
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Michelle L Wolff, Hospital de Clinicas de Porto Alegre/ Universidade Federal do Rio Grande do Sul
  • Study Chair: Carisi A Polanczyck, PhD, Federal University of Rio Grande do Sul
  • Study Chair: José E Dolci, PhD, Faculdade de Ciências Médicas da Santa Casa de São Paulo

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2010

Primary Completion (Actual)

October 1, 2011

Study Completion (Actual)

October 1, 2011

Study Registration Dates

First Submitted

October 17, 2011

First Submitted That Met QC Criteria

October 20, 2011

First Posted (Estimate)

October 24, 2011

Study Record Updates

Last Update Posted (Actual)

January 17, 2019

Last Update Submitted That Met QC Criteria

January 16, 2019

Last Verified

January 1, 2019

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Quality of Life

Clinical Trials on No iInferior turbinate surgery

3
Subscribe